Warning: session_start(): open(/opt/alt/php74/var/lib/php/session/sess_754f3d169b71760443e3d79c4ebf94e4, O_RDWR) failed: Disk quota exceeded (122) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278

Warning: session_start(): Failed to read session data: files (path: /opt/alt/php74/var/lib/php/session) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278
New York's Medical Marijuana Market Continues to Grow Rapidly - Mushroomstocks | Mushroomstocks
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

New York’s Medical Marijuana Market Continues to Grow Rapidly

Aug 3, 2017 • 11:04 AM EDT
4 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

New York’s medical marijuana market has been growing at rapid rates and this is a trend that investors need to watch.

After the New York State Department of Health added chronic pain to the list of approved indications, the number of certified patients has increased by more than 70%.

Although the medical marijuana market is still small (25,726 certified patients as of August 1st), the state recently passed legislation to add post-traumatic stress disorder (PTSD) to the list of qualifying conditions and is currently awaiting a final decision by the governor.

If PTSD is approved as a qualifying condition, it will be a catalyst for patient numbers.

iAnthus Plants its Flag in New York

Over the last few months, we have seen several Canadian medical marijuana firms deploy capital and make acquisitions in the United States market.

Today, iAnthus Capital Holdings (IAN.CN) (ITHUF) announced that its proposed acquisition of Valley Agriceuticals was approved by the New York State Department of Health.

In June, iAnthus agreed to acquire Gloucester Street Capital and its wholly owned subsidiaries, Valley Agriceuticals and Valley Agriceuticals Real Estate, LLC for $17.3 million ($2.3 million in cash and $15.0 million in stock). Up to an additional 5 million shares may be issued if Valley Agriceuticals reaches 15,000 active patient registrations by December 31, 2020.

The proposed acquisition provides iAnthus with significant infrastructure and includes Valley Agriceuticals’ cultivation campus in Wallkill, NY. The property includes 136 acres of land that is currently zoned for cannabis cultivation as well as a 6,500-square foot custom-built cultivation and processing facility.

A Strategic Location and Opportunity

Valley Agriceuticals was officially granted a license as a registered organization under New York state’s medical marijuana program. With this approval, iAnthus expects the acquisition to be completed in the third quarter of 2017.

Under the license, Valley Agriceuticals has been granted dispensary locations in Brooklyn, Dutchess County, Oneida County and Suffolk County, as well as approval for cultivation and manufacturing operations in its facility in Wallkill, NY.

With the dispensary location in Brooklyn, Valley Agriceuticals will have a presence in the second most densely populated county in the United States (estimated 2.6 million residents). The Suffolk County location is also significant and has approximately 1.5 million residents.

An Attractive Opportunity

We are favorable on iAnthus’ leverage to the New York State medical marijuana market and expect this acquisition to be beneficial for the company’s long-term outlook.

Although New York’s medical marijuana market got off to a slow start, we expect the industry to record strong growth if PTSD is added as a qualifying condition. Over the next year, we expect to see several new conditions included in the state’s program and believe this is a story to watch. 

Stay up to date on the GreenRush by subscribing to Mushroomstocks… 

Important Investor Disclosures 

This report was authored by and is property of Mushroomstocks.  All information and data relied upon in drafting this report is publicly available.  The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report.  Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice.  Any projections or other information generated by Mushroomstocks regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results.  None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment.  This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation.  The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals.  It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction.  Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks.  The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission.  Please contact a Financial Advisor for professional advice regarding any and all securities investments.  This report is intended for informational purposes only

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Mushroomstocks.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.

Fatal error: Uncaught ErrorException: md5_file(/home/useaicwl/public_html/wp-content/litespeed/css/7e2503e6b34f9c01f3839ed84b07a3d3.css.tmp): failed to open stream: No such file or directory in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php:126 Stack trace: #0 [internal function]: litespeed_exception_handler(2, 'md5_file(/home/...', '/home/useaicwl/...', 126, Array) #1 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php(126): md5_file('/home/useaicwl/...') #2 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(797): LiteSpeed\Optimizer->serve('https://mushroo...', 'css', true, Array) #3 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(319): LiteSpeed\Optimize->_build_hash_url(Array) #4 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(252): LiteSpeed\Optimize->_optimize() #5 /home/useaicwl/public_html/wp-includes/class-wp-hook.php(310): LiteSpeed\Optimize->f in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php on line 126